HG-7-86-01
HG-7-86-01 is a type II, potent, and selective tyrosine kinase inhibitor designed to target the drug-resistant Bcr-Abl T315I mutant in chronic myeloid leukemia (CML) . It demonstrates robust antiproliferative effects in vitro and has shown efficacy in preclinical CML models, supporting its use as a valuable research tool in oncology and kinase inhibitor development.
Product Specifications
CAS Number
1258391-14-8
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.07% (May vary between batches)
Solubility
DMSO:2 mg/mL (3.56 mM)
Smiles
O=C (NC=1C=C (C=C (C1) C (F) (F) F) N2C=NC (=C2) C) C3=CC=CC (=C3) C4=NC=5SC (=NC5C=C4) NC (=O) C6CC6
Molecular Formula
C28H21F3N6O2S
Molecular Weight
562.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400062-100 1x 100 µL
Granulocyte Marker (BM-2), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880709-100 1x 100 µL
Human Kappa Light Chain (KLC709), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 